Feature | April 09, 2015

SCAI Survey Finds Work-Related Injury Rising Among Interventional Cardiologists

Despite increased awareness and education, orthopedic and radiation-related injuries are still increasing

SCAI, survey, interventional cardiologists, work injury, orthopedic, radiation

April 9, 2015 — Nearly half of interventional cardiologists responding to a survey conducted by the Society for Cardiovascular Angiography and Interventions (SCAI) reported at least one work-related orthopedic complication. The findings, published in Catheterization and Cardiovascular Interventions, indicate that occupational health issues are on the rise among interventional cardiologists.

A total of 314 interventional cardiologists responded to the email survey fielded in the fall of 2014. The survey focused on orthopedic injuries to the spine, hips, knees and ankle, as well as radiation-associated problems including cataracts and cancers.

“The results of the SCAI survey highlight the unique health risks that interventional cardiologists and cath lab staff face as they diagnose and treat cardiovascular disease,” said Lloyd W. Klein, M.D., FSCAI, lead author of the paper and professor of medicine at Rush Medical College in Chicago. “Most concerning is the fact that these risks have increased since interventional cardiologists were last surveyed in 2004. The health and safety of our patients is always our top priority, but these findings point to a very real need to address workplace safety for interventional cardiologists and cath lab staff.”

The survey found at least one orthopedic injury in 49 percent of practicing interventional cardiologist respondents, a finding that significantly correlated with age and was associated with annual case volume. A total of 6.9 percent of operators indicated they have had to limit the number of procedures they perform due to radiation exposure, and 9.3 percent have taken a health-related period of absence. The incidence of radiation-related conditions—including skin injuries, cataracts and hematologic and cancerous diseases—all were within the 5 percent range.

“Interventional practice has changed over the last decade,” said Klein. “Case volume and complexity, as well as procedural time and radiation exposure, have increased. While technologies to safeguard operators from radiation exposure have emerged, their adoption has been limited to lightweight lead aprons and low-dose imaging systems.”

Though SCAI and other societies emphasize compliance with personal dosimeter use, the survey suggests less than optimal use. Among respondents, 18.5 percent of respondents reported occasionally failing to wear a badge and 28.6 percent said they never wore one. Less has been accomplished to protect interventional cardiologists from work-related orthopedic issues associated with wearing protective attire.

Work-related absences have decreased since 2004, suggesting that interventional cardiologists continue working despite injuries.

“While awareness of cath lab safety is increasing, there is still a sizable opportunity to reduce the risks associated with delivering interventional therapies,” said SCAI 2014-15 President Charles Chambers, M.D., FSCAI. “The keys to success will include continuing to develop safer equipment and shields, and educating operators and their staff to consistently practice occupational safety.” 

For more information: www.scai.org

Related Content

Tryton Side Branch Stent Recognized With Premier Technology Breakthrough Award
News | Stents Bifurcation| September 21, 2017
September 21, 2017 — Cardinal Health and Tryton Medical Inc.
DISRUPT BTK Study Shows Positive Results With Lithoplasty in Calcified Lesions Below the Knee
News | Peripheral Artery Disease (PAD)| September 20, 2017
Shockwave Medical reported positive results from the DISRUPT BTK Study, which were presented at the annual...
Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Mississippi Surgical and Vascular Center Uses Toshiba Ultimax-i FPD to Save Patients' Limbs
News | Angiography| September 14, 2017
The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease...
Sponsored Content | Videos | Structural Heart Occluders| September 13, 2017
Ziyad Hijazi, M.D., MPH, MSCAI, FACC, director of the cardiac program and chair of the Department of Pediatrics at Si
Philips Showcases Integrated Vascular Solutions at VIVA 2017
News | Peripheral Artery Disease (PAD)| September 13, 2017
Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference in Las Vegas from...
Overlay Init